Drug Trial Radar · NCT02141672
AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV)
Last checked: Nov 19, 2026Latest source record: May 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
265
Actual
Start
Jun 2014
Primary completion
Jul 2016
Study completion Jan 2017
Sponsor
- Lead sponsor
- Aurinia Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- May 19, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the efficacy of 2 doses of voclosporin compared to placebo in achieving complete remission after 24 weeks of therapy in subjects with active lupus nephritis.
Conditions
- Lupus Nephritis
Interventions
Voclosporin High DoseDrug
Voclosporin Low DoseDrug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects Achieving Complete Renal Remission at 24 WeeksTime frame: week 24
Locations
86 sites in 20 countries. Site status is shown where the registry gives one.
AURA-LV Site
Los Angeles, California
AURA-LV Site
Palo Alto, California
AURA-LV Site
Gainesville, Florida
AURA-LV Site
Miami, Florida
AURA-LV Site
Farmington Hills, Michigan
AURA-LV Site
Brooklyn, New York
AURA-LV Site
New York, New York
AURA-LV Site
Chapel Hill, North Carolina
AURA-LV Site
Charlotte, North Carolina
AURA-LV Site
Columbus, Ohio
AURA-LV Site
Hershey, Pennsylvania
AURA-LV Site
Chattanooga, Tennessee
AURA-LV Site
Dallas, Texas
AURA-LV Site
Houston, Texas
AURA-LV Site
Dhaka, Bangladesh
AURA-LV Site
Dhaka, Bangladesh
AURA-LV Site
Minsk, Belarus
AURA-LV Site
Minsk, Belarus
AURA-LV Site
Minsk, Belarus
AURA-LV Site
Vitebsk, Belarus
AURA-L Site
Plovdiv, Bulgaria
AURA-LV Site
Sofia, Bulgaria
AURA-LV Site
Sofia, Bulgaria
AURA-LV Site
Varna, Bulgaria
AURA-LV Site
Hong Kong, China
AURA-LV Site
Guayaquil, Ecuador
AURA-LV Site
Quito, Ecuador
AURA-LV Site
Tbilisi, Georgia
AURA-LV Site
Tbilisi, Georgia
AURA-LV Site
Guatemala City, Guatemala
AURA-LV Site
Guadalajara, Mexico
AURA-LV Site
Mexicali, Mexico
AURA-LV Site
Oaxaca City, Mexico
AURA-LV Site
Tlalpan, Mexico
AURA-LV Site
Tlalpan, Mexico
AURA-LV Site
Angeles City, Philippines
AURA-LV Site
Batangas, Philippines
AURA-LV Site
Cebu City, Philippines
AURA-LV Site
Davao City, Philippines
AURA-LV Site
Manila, Philippines
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.